Skip to main content
. 2018 Aug 4;35(9):1460–1469. doi: 10.1007/s12325-018-0755-4

Table 2.

Mean medications over time: all eyes and low and high IOP subgroups

All eyes (n = 52) Baseline IOP ≤ 16.5 mmHg (n = 26) Baseline IOP > 16.5 mmHg (n = 26)
Mean medication (n) ± SE* Mean difference (n) Medication change (%) Mean medication (n) ± SE Mean difference (n) Medication change (%) Mean medication (n) ± SE Mean difference (n) Medication change (%)
Baseline 1.6 (0.2) 1.7 (0.2) 1.5 (0.3)
Day 1 0.5 (0.1) − 1.1 − 68.8 0.7 (0.2) − 1.0 − 58.8 0.4 (0.2) − 1.1 − 73.3
Week 1 0.6 (0.2) − 1.0 − 62.5 0.7 (0.2) − 1.0 − 58.8 0.6 (0.2) − 0.9 − 60.0
Month 1 0.7 (0.1) − 0.9 − 56.3 0.8 (0.2) − 0.9 − 52.9 0.6 (0.2) − 0.9 − 60.0
Month 3 1.0 (0.2) − 0.6 − 37.5 0.8 (0.2) − 0.9 − 52.9 1.1 (0.3) − 0.4 − 26.7
Month 6 0.8 (0.1) − 0.8 − 50.0 0.7 (0.2) − 1.0 − 58.8 1.0 (0.2) − 0.5 − 33.3
Month 12 0.8 (0.1) − 0.8 − 50.0 0.6 (0.2) − 1.1 − 64.7 1.0 (0.2) − 0.5 − 33.3

*Reported are least squares means and associated standard errors from a mixed model for repeated measure analysis. Per Bonferroni pairwise comparison, the difference from baseline in mean medications is statistically significant at each follow-up visit (P < 0.05) except at month 3 (P = 0.154)